Wir führen Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.
BioNTech is a biotechnology company that focuses on developing personalized immunotherapies for the treatment of cancer and other serious diseases. The company utilizes its proprietary mRNA technology to create vaccines and therapies that are tailored to the genetic makeup of individual patients.
12000 / day
15000 / day
3.2 pages per visit
Domain Rating
Domain Authority
Citation Level
English, etc
BioNTech's proprietary mRNA technology is at the core of its therapeutic and vaccine development, enabling the creation of personalized treatments.
The company specializes in developing immunotherapies that harness the body's immune system to fight cancer.
BioNTech's approach to medicine is highly personalized, aiming to tailor treatments to the genetic profile of each patient.
BioNTech, in partnership with Pfizer, developed one of the first mRNA-based COVID-19 vaccines, demonstrating the potential of its technology in addressing global health crises.
The company engages in numerous research collaborations with academic institutions, pharmaceutical companies, and other biotechnology firms to advance its therapeutic and vaccine development.
Mainz, Germany
Ugur Sahin (CEO), Özlem Türeci (CMO)
Over 1,800 (as of 2021)
NASDAQ: BNTX
Development of the first mRNA-based COVID-19 vaccine in partnership with Pfizer.
BioNTech continues to explore the application of its mRNA technology in vaccines for other infectious diseases and in the development of novel cancer immunotherapies.
Security headers report is a very important part of user data protection. Learn more about http headers for biontech.de